Fitzgerald Industries International, Inc. Lp (a) Blocking Peptide 33R-8931

Description
A synthetic peptide for use as a blocking control in assays to test for specificity of LPA antibody, catalog no. 70R-10023 Background: LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the protein contains 2-43 copies of kringle-type domains.
Description
A synthetic peptide for use as a blocking control in assays to test for specificity of LPA antibody, catalog no. 70R-10023 Background: LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the protein contains 2-43 copies of kringle-type domains.

Suppliers

Company
Product
Description
Supplier Links
Fitzgerald Industries International, Inc.
Acton, MA, USA
Lp (a) Blocking Peptide
33R-8931
Lp (a) Blocking Peptide 33R-8931
A synthetic peptide for use as a blocking control in assays to test for specificity of LPA antibody, catalog no. 70R-10023 Background: LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the protein contains 2-43 copies of kringle-type domains.

A synthetic peptide for use as a blocking control in assays to test for specificity of LPA antibody, catalog no. 70R-10023
Background:
LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the protein contains 2-43 copies of kringle-type domains.

Supplier's Site

Technical Specifications

  Fitzgerald Industries International, Inc.
Product Category Biological Materials
Product Number 33R-8931
Product Name Lp (a) Blocking Peptide
Unlock Full Specs
to access all available technical data

Similar Products